Industry Background:
Phosphate binders also are known as phosphorous binders is the medication used to prevent the body from absorbing the phosphorus from the food we consume. The phosphate binders help in passing the excess amount of phosphorous out of the body through stool results in the reduction of the number of phosphates in the blood. They are taken within 5 to 10 minutes immediately after the meals or snacks which works in two ways, some phosphate binders work like a sponge by soaking up the phosphates in the food preventing it from getting into the blood. Instead it gets carried through the digestive tract and eliminated through stool and some phosphate binders work like a magnet. There are calcium-based, iron-based and aluminum-based phosphate binders, etc. available in the market. The increasing number of kidney stone disease and hyperphosphatemia cases across the world is driving the market.This growth is primarily driven by Increasing Geriatric Population Across the Globe
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | K Units |
Value Unit | USD (Million) |
Key Companies in Study | Vifor Pharma (Switzerland), Shire Pharmaceutical Group Plc. (United States), Sanofi S.A (Genzyme Corporation) (France), Cipla Limited (India), Norwich Pharma Service (United States), Mylan N.V. (Meda AB) (United States), Lupin Limited (India), Keryx Biopharmaceuticals, Inc. (United States), Incepta Pharmaceuticals Limited (Bangladesh) and Akebia Therapeutics, Inc. (United States) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Pharmaceuticals sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Vifor Pharma (Switzerland), Shire Pharmaceutical Group Plc. (United States), Sanofi S.A (Genzyme Corporation) (France), Cipla Limited (India), Norwich Pharma Service (United States), Mylan N.V. (Meda AB) (United States), Lupin Limited (India), Keryx Biopharmaceuticals, Inc. (United States), Incepta Pharmaceuticals Limited (Bangladesh) and Akebia Therapeutics, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
The phosphate binder market is fragmented with many players prevailing in the market. The companies are currently focusing on research and development on the phosphate binder to enhance their effectiveness according to the regulatory compliances. The companies are also making their way in merger and acquisition activities to expand their product portfolio along with sales channels to sustain in the market.
Market Drivers
- Increasing Geriatric Population Across the Globe
- Rising Number of Chronic Kidney Diseases Among a Large number of People
Market Trend
- Continuous Technological Advancements and Research and Development in Phosphate Binder
- Use of Iron-Based Phosphate Binders is Constantly Increasing
Restraints
- Adherence Standards on Phosphate Binders
- Allergic Reactions with Consumption of Phosphate Binders
Opportunities
Increasing Government Investments in Healthcare Infrastructure and Pharmaceutical Studies and Surging Medical Spending by People will Boost the Phosphate Binder
Challenges
Labelling and Supply Chain Issues with Phosphate Binders
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Phosphate Binder Study Sheds Light on
The Phosphate Binder Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Phosphate Binder industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Phosphate Binder industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.